Andrographis Paniculata Extract
  • Andrographis Paniculata Extract

    Andrographis Paniculata Extract

  • Andrographis Paniculata Extract

    Latin Name: Andrographis paniculata nees

    Plant Origin and Distribution:Andrographis Paniculata ( Burm.f ) Ness

    Part of Used:leaf

    Active Ingredient:Andrographolide

    Specification Available:5%;10%;20%;30%;50%;90%;95%

    Appearance:Brown to white crystalline fine powder


Andrographis paniculata extract andrographolides is a labdane diterpenoid that is the main bioactive component of the medicinal plant Andrographis paniculata.

Andrographis paniculata extract andrographolides is an extremely bitter substance extracted from the stem and leaves of the andrographis paniculata, which is grown for medicinal purposes in China.

Andrographis paniculata extract andrographolides, the bitter constituent of andrographis panaculata, is believed to have stimulate the immune system, act as an anti-inflammatory, and provide liver protection.



1.It can protect skin from pimples.

2.It can be used as blood sugar reducer.

3.It has effect on fighting bacterial activity.

4.It can kill intestinal worms and supports intestines.

5.It can reduce swelling and cuts down exudation from capillaries.

6.It also can reduce diarrhea and symptoms arising from bacterial infections.

7.It has the function of promoting mucus discharge from the respiratory system.

8.It can help reduce symptom severity in people with common colds.



1.Applied in veterinary field, andrographis paniculata extract andrographolides is made into pulvis to treat acute bacillary dysentery, gastro-enteritis and pneumonia of poultry and livestock.

2.Applied in pharmaceutical field,andrographis paniculata extract andrographolides is usually made into tablets, soft capsule,to treat acute bacillary dysentery, gastroenteritis ,cat fever, amygdalitis, faucitis, pneumonia, phthisis and so on.

About Us
Company Profile
Company Culture
Standard herbal extract
Ratio extract
Natural plant powder
Company News
Industry News
Cases 1
Contact Us
Contact Us